Skip to content

Perrigo Co PLC

PRGO· NYSECore metricsCIK 1585364

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -2.24%
Market cap
$2.25B
138.8M shares
Filings
1,039
$988.60M
Q3 2026−2.8% FY25 yoy
-$27.50M
Q3 2026N/M FY25 yoy
$23.10M
Q3 2026N/M FY25 yoy
$19.60M
Q3 2026derived−40.7% FY25 yoy
-$0.20
Q3 2026N/M FY25 yoy
$436.60M
Q3 2026−4.9% FY25 yoy
$2.25B
—
0.5×
0.9×
7.49%
7.13%

Twelve months to Sep 26, 2026 · derived

Price

$16.18+13.23%+$1.89past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$4.25BFY 2025
$5.28B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$4,253,100,000reported
FY 20242024-12-31$4,373,400,000reported
FY 20232023-12-31$4,655,600,000reported
FY 20222022-12-31$4,451,600,000reported
FY 20212021-12-31$4,138,700,000reported
FY 20202020-12-31$4,088,200,000 revisedreported
FY 20192019-12-31$3,869,900,000 revisedreported
FY 20182018-12-31$4,731,700,000reported
FY 20172017-12-31$4,946,200,000reported
FY 20162016-12-31$5,280,600,000reported
FY 20152015-06-27$4,227,100,000 revisedreported
FY 20142014-06-28$3,914,100,000 revisedreported

Capital returns

Dividends and buybacks · FY2013 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025$159.30M—$159.30M$1.16137.65M sh+0.9%109.8%
FY2024$152.50M—$152.50M$1.10136.46M sh+0.7%62.3%
FY2023$149.70M—$149.70M$1.09135.52M sh+0.6%49.3%
FY2022$142.40M$0.00$142.40M$1.04134.65M sh+0.6%67.5%
FY2021$129.60M$0.00$129.60M$0.96133.78M sh+0.5%3085.7%

Segments

Revenue by Segments, FY2018 to FY2025FY2018CSCA · FY2018 · $2.41BCSCI · FY2018 · $1.40BRX Pharmaceuticals · FY2018 · $920.80MFY2019CSCA · FY2019 · $2.49BCSCI · FY2019 · $1.38BFY2020CSCA · FY2020 · $2.69BCSCI · FY2020 · $1.40BFY2021CSCA · FY2021 · $2.69BCSCI · FY2021 · $1.45BFY2022CSCA · FY2022 · $2.93BCSCI · FY2022 · $1.53BFY2023CSCA · FY2023 · $2.96BCSCI · FY2023 · $1.69BFY2024CSCA · FY2024 · $2.69BCSCI · FY2024 · $1.68BFY2025CSCA · FY2025 · $2.59BCSCI · FY2025 · $1.67B
LineFY2025ShareChange
CSCA$2.59B61%−4.0%
CSCI$1.67B39%−0.7%
RX Pharmaceuticals———
Total$4.25B

From the 10-K filed Feb 26, 2026PRGO

Pharmaceutical preparations

Perrigo Co PLC is the 20th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Perrigo Co PLC · CIK 1585364 · Engraved from SEC EDGAR